RGD Mimetics containing a central hydantoin scaffold: αVβ3 vs αIIbβ3 selectivity requirements
- 17 January 2000
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 10 (2) , 179-182
- https://doi.org/10.1016/s0960-894x(99)00661-7
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Benzimidazole derivatives as arginine mimetics in 1,4-benzodiazepine nonpeptide vitronectin receptor (αvβ3) antagonistsBioorganic & Medicinal Chemistry Letters, 1998
- Discovery of an imidazopyridine-containing 1,4-benzodiazepine nonpeptide vitronectin receptor (αvβ3) antagonist with efficacy in a restenosis modelBioorganic & Medicinal Chemistry Letters, 1998
- Stereoisomeric Peptide Libraries and Peptidomimetics for Designing Selective Inhibitors of the αvβ3 Integrin for a New Cancer TherapyAngewandte Chemie International Edition in English, 1997
- Discovery of Potent Nonpeptide Vitronectin Receptor (αVβ3) AntagonistsJournal of Medicinal Chemistry, 1997
- Recent advances in cell adhesion molecules and extracellular matrix proteins: potential clinical implicationsDrug Discovery Today, 1997
- β1 integrins and osteoclast function: Involvement in collagen recognition and bone resorptionBone, 1996
- 1H-Pyrazole-1-carboxamidine hydrochloride an attractive reagent for guanylation of amines and its application to peptide synthesisThe Journal of Organic Chemistry, 1992
- Integrins: Versatility, modulation, and signaling in cell adhesionCell, 1992
- Arginyl-glycyl-aspartic acid (RGD): a cell adhesion motifTrends in Biochemical Sciences, 1991
- New Perspectives in Cell Adhesion: RGD and IntegrinsScience, 1987